We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.35 | -1.22% | 28.25 | 28.00 | 28.50 | 28.50 | 28.25 | 28.50 | 657,832 | 16:12:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 48.48M | -776k | -0.0011 | -256.82 | 190.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/6/2019 12:48 | You have to feel news is due in the next month | discojames | |
04/6/2019 20:49 | All of the resolutions passed and were not interesting to begin with | discojames | |
01/6/2019 08:51 | Any one go to the AGM? | loafofbread | |
29/5/2019 18:37 | Think we need to call the vet... | muchodinero | |
29/5/2019 10:11 | The dog is sick today... | muchodinero | |
24/5/2019 10:23 | life in the old dog? | qs99 | |
14/5/2019 21:45 | Well I wonder if Trevor and the management team have engaged with the likes of GSK regarding the FLU-v vaccine seeing that GSK have now abandoned their own versions of a universal flu vaccine after phase 1 failure. The trouble is that the longer that Imutex/HVO sit on the Flu-v vaccine, the potential for competitors to advance their own universal vaccines. Let's hope that HVO/Imutex have already started negotiations on phase 3 trials..... | muchodinero | |
10/5/2019 12:59 | Anyone else with a view on this? | qs99 | |
10/5/2019 12:40 | Nice find! And no I wasn't so thanks. Fingers Xd then! Must admit, thought with the end of day tick up yesterday it may have followed on today, but not so far....DYOR | qs99 | |
10/5/2019 11:13 | I see that within the article a nice little cryptic choice of words towards the end of this extract......"In its announcement, GSK said the decision to cut the two programs were made following an analysis of available research results, including interim data from an ongoing Phase I study of the flu vaccine. GSK said it remains committed to further research in flu including pursuing other approaches.". Make your own minds up as to what that last bit means? | muchodinero | |
10/5/2019 10:29 | I assume that you guys are aware of the news that GSK have abandoned their universal flu vaccine.... hxxps://www.pharmali | muchodinero | |
10/5/2019 08:32 | Needs to break and stay above 30p IMO to show real legs again.... | qs99 | |
10/5/2019 08:19 | Yup, ticked up again, let's see whether we can head into the weekend with a material rise. Fingers Xd bodes well for next week! DYOR | qs99 | |
10/5/2019 08:16 | Looking perky | qs99 | |
10/5/2019 08:15 | Lets hope so. | loafofbread | |
09/5/2019 23:21 | Something is stirring here, watch this space | discojames | |
24/4/2019 15:18 | Good call mam fach on switching to MTPH, flying today. Frustrating wait here at HVO. | azuli | |
12/4/2019 08:32 | not a brilliant update yesterday.....sort of reads......we're jogging along and we the management team are enjoying our large salaries and free shares, but as a BOD we lack the confidence to stick our hands in our pockets and buy shares as it's too risky; we'd prefer that the shareholders bare all the risks, as we may be able to milk them for more cash next year....Aimho adyor!!! | muchodinero | |
11/4/2019 13:55 | Yes, but they've already had a good chunk of that money in. Contract liabilities are ~£6m which is income invoiced and paid but not recognised as the work has not been completed (in effect payments up front). 30% margin on the remaining £15m gives £3m to cover costs for the remainder of the year | tonyw99 | |
11/4/2019 13:46 | I see yes, but they have already signed £21m not included in the interims, i believe | discojames | |
11/4/2019 13:33 | Disco, it does (at 31st Dec) .....but then read the notes on going concern (Pg6) which state £8.3m at end of March. Para 3 & 4 are indicating the risk in Q4 (Oct-Dec). If they win new contracts it will be ok but generally they'd need to signing those in the next 3 mths | tonyw99 | |
11/4/2019 13:27 | The cash may see them through to profits, but with over 75% of shares with II's it shouldn't be a problem raising cash. | andrewsr |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions